We are the voice of the home and alternate site infusion
community and the patients we serve
While Congress intended to create a comprehensive Medicare home infusion benefit for Part B DME drugs in the 21st Century Cures Act, flawed implementation by CMS has led to major access issues for Medicare beneficiaries.
Medicare’s coverage of home infusion therapy is limited. Only about 40 drugs therapies are covered under the Part B DMEPOS benefit, leaving the vast majority of home infused-drugs covered by Part D prescription drugs plan.
NHIA has developed recommendations for commercial, Medicaid and Medicare Advantage payors to reduce administrative burden and remove barriers to accessing certain infusion services.
NHIA represents and advances the interests of organizations that provide medically necessary infusion therapies and products to patients in alternate sites of care. As part of the association’s efforts to advance the industry, we monitor and advocate on a range of important health care issues. We are focused on clinical and business best-practices that may be subject to legislation, regulation, accreditation, practices of health plans/third party payers, and more. Learn more about the issues impacting home and alternate site infusion and how to use your voice to ensure all patients have access to high quality infusion services so they can lead healthy, independent lives.
On Tuesday, September 19, 2023, the House Energy & Commerce Health Subcommittee held a legislative hearing, “Examining Policies to Improve Seniors’ Access to Innovative Drugs, Medical Devices, and Technology.” Home infusion was discussed at least
NHIA submitted comments on a CMS PFS proposed rule (CMS-1784-P) that would affect Medicare classification and coverage of self-administered drugs, certain biologics and coding and billing requirements related to the use of single dose containers
NHIA responded to an FDA request for comment on “Increasing Patient Access to At-Home Use Medical Technologies,” applauding the agency for recognizing the importance of facilitating access to care in the home.
NHIA submitted comments to CMS on the proposed 2024 home health payment rule. CMS did not mention the HIT services benefit in its 2024 rulemaking, however, NHIA believes it is important to continue advocating on
